Document is current
Any future updates will be listed below
-
Authors
Coindard, Guillaume http://orcid.org/0000-0003-3809-7306
Acquadro, Michaël http://orcid.org/0000-0001-9040-9149
Chaumont, Raphaël
Arnould, Benoit http://orcid.org/0000-0003-3160-5347
Boisnault, Philippe
Collignon-Portes, Rachel
Duhot, Didier
Raineri, François
Tugaut, Béatrice http://orcid.org/0000-0002-6525-2845
Aubin, Henri-Jean http://orcid.org/0000-0002-6604-6672
- License Information
-
More Information
Article History
Received: 21 May 2021
Accepted: 14 December 2021
First Online: 14 January 2022
Declarations
:
: The present study was conducted in compliance with local ethical principles and the list of the members of the SFMG was submitted and approved by the French National Commission for Data Processing and Privacy (‘Commission Nationale de l’Informatique et des Libertés’) and the French National Medical Association (‘Conseil National de l’Ordre des Médecins’). This study collected informed consent from all primary care physicians that participated.
: Not applicable.
: Henri-Jean Aubin has participated at advisory boards for Pfizer, Johnson & Johnson for the development of smoking cessation medications. The other authors declare that they have no competing interest.
